CytomX Therapeutics, Inc. (CTMX)
3.71
+0.07
(+1.92%)
USD |
NASDAQ |
May 20, 16:00
3.71
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Market Cap : 807.68M for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.824B |
| Rigel Pharmaceuticals, Inc. | 535.64M |
| Ovid Therapeutics, Inc. | 446.07M |
| Gossamer Bio, Inc. | 50.04M |
| Mirum Pharmaceuticals, Inc. | 5.919B |
Market Cap Related Metrics
| PS Ratio | 16.74 |
| Price to Book Value | 2.524 |
| Price | 3.71 |
| Earnings Yield | -9.80% |